Management of Adverse Events Associated with Cabozantinib Treatment in Patients with Advanced Hepatocellular Carcinoma

Abstract Electronic supplementary material: The online version of this article (10.1007/s11523-020-00736-8) contains supplementary material, which is available to authorized users. Authors: Gabriel Schwartz, Julianne O. Darling, Malori Mindo, Lucia Damicis Affiliations: grid.266102.10000 0001 2297 6811Gastrointestinal Medical Oncology Clinic, University of California San Francisco, 1825 Fourth St, Fourth Floor, San Francisco, CA 94158 USA; grid.411569.e0000 0004 0440 2154Indiana University Health Simon Cancer Center, Indianapolis, IN USA; grid.266102.10000 0001 2297 6811Department of Medicine, University of California San Francisco, San Francisco, CA USA;